Repositorio Dspace

Improving Anxiety Related to Chronic Pain Through a Sleep Circadian Intervention Program: A Pilot Study

Mostrar el registro sencillo del ítem

dc.contributor.author López-Monzoni, Sonia
dc.contributor.author Hernando-Benito, Gloria
dc.contributor.author Romero-Peralta, Sofia
dc.contributor.author Silgado-Martínez, Laura
dc.contributor.author Viejo-Ayuso, María-Esther
dc.contributor.author Álvarez-Balado, Leticia
dc.contributor.author Rodríguez-Matarranz, Enrique
dc.contributor.author Forne-Izquierdo, Carles
dc.contributor.author Sánchez-de-la-Torre, Manuel
dc.contributor.author Masa, Juan-Fernando
dc.contributor.author Barbe, Ferran
dc.contributor.author García-Río, Francisco
dc.contributor.author Martínez-Nicolas, Antonio
dc.contributor.author García-Mediano, Belén
dc.contributor.author Solano-Pérez, Esther
dc.contributor.author Mediano, Olga
dc.date.accessioned 2026-03-09T08:36:59Z
dc.date.available 2026-03-09T08:36:59Z
dc.date.issued 2025-01-03
dc.identifier.citation López-Monzoni S, Hernando Benito G, Romero-Peralta S, Silgado-Martínez L, Viejo-Ayuso ME, Álvarez-Balado L, et al. Improving Anxiety Related to Chronic Pain Through a Sleep Circadian Intervention Program: A Pilot Study. Behavioral Sciences. 3 de enero de 2025;15(1):40. doi:10.3390/bs15010040
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/25018
dc.description.abstract The limitations of pharmacological treatments for chronic pain have become increasingly evident: dependency, side effects, resistance, and diminishing efficacy. The urgent need for innovative solutions has become a compelling focus for improving patient outcomes. Innovative non-pharmacological approaches, such as sleep management, as a strategy to reduce opioid consumption and pain control are needed. The aim was to evaluate the impact of a Sleep and Circadian Intervention Program (SCIP) in the control of chronic musculoskeletal pain (CMP). This was a randomized clinical trial (NCT03646084), in which 49 CMP patients were assigned to SCIP (n = 15, mean age 51 years and 40% women) or non-SCIP groups (n = 26, 53 years and 61.5% women). Outcomes were evaluated after 6 months through self-reported questionnaires (pain intensity, physical function, depression/anxiety, and quality of life (QoL)). The SCIP group was assessed by polysomnography and specific questionnaires and was treated for diagnosed sleep disorders according to clinical guidelines. This population showed a moderate pain intensity at baseline, important deterioration of QoL and pathological anxiety/fear related to pain. Fifty percent of them presented restless leg syndrome, 60% moderate/severe insomnia, and 62.5% sleep apnea. During the follow-up, the SCIP group presented a greater reduction in the abnormal risk group for anxiety (from 73.3% to 46.7%) and depression (from 53.3% to 33.3%) on the Hospital Anxiety and Depression Scale compared to the non-SCIP group (from 40% to 29.2% and 33.3% to 29.2%, respectively). Also, a positive significant effect on anxiety/fear related to pain was found in the Pain Anxiety Symptoms Scale multivariable model, with an important improvement in symptoms. The application of SCIP in CMP patients improved anxiety and controlled associated sleep disorders, highlighting the impact on insomnia. Larger studies are needed for better understanding of the sleep intervention in CMP control.
dc.language.iso eng
dc.publisher MDPI
dc.rights Atribución/Reconocimiento 4.0 Internacional
dc.rights.uri https://creativecommons.org/licenses/by/4.0/deed.es
dc.title Improving Anxiety Related to Chronic Pain Through a Sleep Circadian Intervention Program: A Pilot Study
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 39851844
dc.relation.publisherversion https://www.mdpi.com/2076-328X/15/1/40
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.3390/bs15010040
dc.journal.title Behavioral Sciences
dc.identifier.essn 2076-328X


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta